Replies to post #60953 on Options Wonderland

[3xBuBu]

FDA drug approval decision: Arena Pharmaceuticals'(ARNA) lorcaserin for obesity on Oct. 22
FDA drug approval decision: Vivus'(VVUS) Qnexa for obesity on Oct. 28.
FDA drug approval decision: Biodel's(BIOD) Linjeta for diabetes on Oct. 30.

As of now:
ARNA @1.57
VVUS @6.63
BIOD @5.28
ARIA @3.65
PPHM @1.48

more Key Dates for October Biotech Calendar:
http://www.thestreet.com/story/10874282/1/biotech-calendar-key-dates-for-october.html